Pain News and Research

Latest Pain News and Research

Medtronic, Aetna team up to help insured members with uncontrolled type 2 diabetes

Beginning this month, Aetna and Medtronic, Inc. will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy.

From Medtronic 4 Mar 2014

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported financial results for the three and twelve months ended December 31, 2013.

4 Mar 2014

Angry outbursts increase heart attack risk

Call it what you will - getting red in the face, hot under the collar, losing your cool, blowing your top - we all experience anger. And while we know that anger is a normal, sometimes even beneficial emotion, we're also aware of the often harmful connection between anger and health. New research from Beth Israel Deaconess Medical shows an even more compelling reason to think about getting anger in check - a nearly fivefold increase in risk for heart attack in the two hours following outbursts of anger.

4 Mar 2014

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced that it intends to offer and sell, subject to market and other conditions, $150,000,000 of shares of its common stock in an underwritten public offering.

4 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Doctors offer ways to help protect kidneys

The kidneys, two very important organs located in your back, help to continuously clean out wastes and extra fluid from your body. One in 10 Americans develops kidney disease due to diabetes, high blood pressure or a family history of kidney failure.

3 Mar 2014

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., has submitted an application for marketing authorization for EYLEA (aflibercept) Injection for the treatment of patients with diabetic macular edema (DME) to the Japanese Ministry of Health, Labour and Welfare.

3 Mar 2014

Many children admitted with mental health problems mistaken for physical disease

Many children are admitted to general acute wards with mental health problems mistaken for physical disease.

3 Mar 2014

Five women scientists to receive ‘L’Oréal-UNESCO For Women in Science Awards'

On March 19th the L'Oréal Foundation and UNESCO will present the L'Oréal-UNESCO For Women in Science awards to five outstanding women scientists.

3 Mar 2014

Photoreactive compounds open new routes to treatment of neurological diseases

Photoreactive compounds developed by scientists of Ludwig-Maximilians-Universitaet (LMU) in Munich directly modulate nerve-cell function, and open new routes to the treatment of neurological diseases, including chronic pain and certain types of visual impairment.

3 Mar 2014

Storytelling can help doctors recall opioid guidelines

In the fight against a nationwide prescription opioid abuse epidemic, Penn Medicine researchers are using storytelling to help doctors recall important, potentially lifesaving national guidelines on how to prescribe these medications.

3 Mar 2014

Despite prevention strategies, suicide rates among young men remain high

Suicide among young men is a major public health concern in many countries, despite great efforts to find effective prevention strategies.

3 Mar 2014

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).

3 Mar 2014

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

3 Mar 2014

New study may open door to better diagnosis, treatment for chronic insomnia

Johns Hopkins researchers report that people with chronic insomnia show more plasticity and activity than good sleepers in the part of the brain that controls movement.

3 Mar 2014

Xeltis completes enrollment for study of spontaneous tissue growth technology

Xeltis, a privately held medical device company dedicated to transforming standards of care in heart valve replacement and vascular surgery, has announced that it has finished enrollment in a five-patient feasibility study of implantable products intended to enable for the first time the spontaneous growth of natural, healthy heart valves and vessels. With its proprietary technology, the company has pioneered an entirely new therapeutic category called Endogenous Tissue Growth, or ETG, in which surgeons use unique implants designed to allow the body to repair itself by growing natural, healthy tissue.

28 Feb 2014

Viewpoints: Questioning the tales of Obamacare woes; Republic replacement MIA; 'mixed messages' on mammograms

Conservatives appear to be really upset that liberals are actually taking on the facts in the anti-Obamacare ads they've been running. How dare you question whether the people in these ads are giving an accurate picture - they're suffering! (Paul Krugman, 2/26).

28 Feb 2014

Another concern related to low birth weight identified

Researchers have identified another concern related to low birth weight - a difference in how the body reacts to drugs, which may last a person's entire life and further complicate treatment of illnesses or diseases that are managed with medications.

28 Feb 2014

Cedars-Sinai neurosurgeon successfully performs CSF repair surgery on patient

When Elizabeth "Beth" Johnson stood up from working at her computer Oct. 28, she noticed "a kind of funny feeling" in the back of her neck. By Nov. 2, the sensation had become an excruciating headache that came on whenever she tried to stand or sit upright.

28 Feb 2014

Loyola University Medical Center offers new high-tech catheter device for treating atrial fibrillation

Loyola University Medical Center is the first hospital in Illinois to offer a new high-tech catheter device that can improve outcomes of patients treated for atrial fibrillation, the most common irregular heartbeat.

28 Feb 2014

Pain News and Research

Latest Pain News and Research

Medtronic, Aetna team up to help insured members with uncontrolled type 2 diabetes

AcelRx Pharmaceuticals announces financial results for fourth quarter and full year 2013

Angry outbursts increase heart attack risk

ACADIA Pharmaceuticals proposes to sell common stock in underwritten public offering

New article explores risks associated with using herbal cannabis for rheumatic conditions

Doctors offer ways to help protect kidneys

Bayer Yakuhin submits marketing authorization application in Japan for EYLEA Injection

Many children admitted with mental health problems mistaken for physical disease

Five women scientists to receive ‘L’Oréal-UNESCO For Women in Science Awards'

Photoreactive compounds open new routes to treatment of neurological diseases

Storytelling can help doctors recall opioid guidelines

Despite prevention strategies, suicide rates among young men remain high

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

New study may open door to better diagnosis, treatment for chronic insomnia

Xeltis completes enrollment for study of spontaneous tissue growth technology

Viewpoints: Questioning the tales of Obamacare woes; Republic replacement MIA; 'mixed messages' on mammograms

Another concern related to low birth weight identified

Cedars-Sinai neurosurgeon successfully performs CSF repair surgery on patient

Loyola University Medical Center offers new high-tech catheter device for treating atrial fibrillation

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in